Clinical Trials Sponsored by Sinocelltech Ltd.

Total 16798 results

Sinocelltech Ltd.

Not yet recruiting

A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma, B-cell

China
Sinocelltech Ltd.

Not yet recruiting

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.

Advanced Malignant Solid Tumours
Sinocelltech Ltd.

Not yet recruiting

A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies

Relapsed or Refractory Hematologic Malignancies
Sinocelltech Ltd.

Not yet recruiting

Evaluate the Safety and Tolerability of SCT650C in Healthy Volunteers

Autoimmune Disease

Australia
Sinocelltech Ltd.

Recruiting

SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Carcinoma

China
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Recruiting

A Phase II Study of SCT1000 in Healthy Women Aged 18 to 45 Years

Randomized | Prevention | Interventional

China
Sinocelltech Ltd.

Recruiting

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
Sinocelltech Ltd.

Completed

The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults

COVID-19

China
Sinocelltech Ltd.

Active, not recruiting

SCT-I10A Plus SCT510 Versus Sorafenib as First-Line Therapy for Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

China
Sinocelltech Ltd.

Unknown

SCT200 Plus Platinum-based Chemotherapy in Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

China
Sinocelltech Ltd.

Unknown

Safety,Efficacy and Pharmacokinetics Evaluation of SCT800 in Previously Treated Paediatric Patients With Severe Haemophilia A.

Hemophilia A
Sinocelltech Ltd.

Unknown

To Evaluate the Efficacy and Safety of SCT510 in the Treatment of Non-small Cell Lung Cancer

Non-squamous Cell Non-small Cell Lung Cancer
Sinocelltech Ltd.

Unknown

Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A

Hemophilia A

China
Sinocelltech Ltd.

Not yet recruiting

Efficacy and Safety of SCT650C in Participants With Axial Spondyloarthritis

Axial Spondyloarthritis

Turkey
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of A Recombinant Protein COVID-19 Vaccine as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

Study on the Antibody Level Against SARS-CoV-2 （COVID-19）in Dazhu County in 2023 (COVID-19)

COVID-19

China
Sinocelltech Ltd.

Recruiting

This Study Will Compare the Efficacy and Safety of SCT510A Administered by Intravitreal Injection (IVT) With Ranibizumab in Patients With wAMD

Wet Age-related Macular Degeneration

China
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C in Population Aged ≥18 Years and Previously Fully Vaccinated With COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Recruiting

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
Sinocelltech Ltd.

Recruiting

A Phase I Safty and Immunogenicity Study of SCT1000 in Healthy Women Aged 18 to 45 Years

HPV Infection Vaccine Safety SCT1000

China
Sinocelltech Ltd.

Not yet recruiting

To Evaluate SCTA01 Treatment of High-risk Outpatients With COVID-19 (MAOP3)

COVID-19 | SARS-CoV-2
Sinocelltech Ltd.

Recruiting

Safety and Efficacy of Long-term Treatment With SCT800 in Previously Treated Hemophilia A Patients.

Hemophilia A

China
Sinocelltech Ltd.

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years

COVID-19 | SARS-CoV-2 Infection

China
Sinocelltech Ltd.

Completed

A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine (SCTV01E)

COVID-19 Pandemic

China
Sinocelltech Ltd.

Active, not recruiting

A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

COVID-19 | SARS-CoV-2 Infection

United Arab Emirates
Sinocelltech Ltd.

Unknown

The Safety and Efficacy of SCTA01 Against COVID-19 in Patients Admitted to High Dependence or Intensive Care

Covid19
Sinocelltech Ltd.

Unknown

SCT-I10A Plus Standard Chemotherapy in First-line Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

China
Sinocelltech Ltd.

Unknown

Safety and Efficacy of SCT-I10A in Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

China
Sinocelltech Ltd.

Unknown

Safety, Tolerability, Pharmacokinetics and Efficacy of SCT-I10A in Patients With Advanced Solid Tumors or Lymphoma

Advanced Solid Tumors or Lymphoma

China
Sinocelltech Ltd.

Unknown

Efficacy and Safety of SCT200 in Patients With Advanced Squamous Non-small Cell Lung Cancer (sNSCLC)

Advanced Squamous Non-small Cell Lung Cancer
Sinocelltech Ltd.

Unknown

Safety, Tolerability and Pharmacokinetics of Recombinant Anti-epidermal Growth Factor Receptor(EGFR) Monoclonal Antibody in Patients With Metastatic Colorectal Cancer

Metastatic Colorectal Cancer
Sinocelltech Ltd.

Not yet recruiting

A Phase III Clinical Trial to Evaluate the Efficacy and Safety of SCTV01E in Healthy People

COVID-19 SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 Years

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Not yet recruiting

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine

COVID-19 | Sars-CoV-2 Infection
Sinocelltech Ltd.

Recruiting

The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19

Covid19

United States, Argentina, Brazil, Chile, Colombia, Mexico, Peru
Sinocelltech Ltd.

Withdrawn

A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine

COVID-19 | SARS-CoV2 Infection
Sinocelltech Ltd.

Withdrawn

A Study to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

COVID-19 | SARS-CoV-2 Infection
Sinocelltech Ltd.

Terminated

SCT-I10A or Placebo Plus Docetaxel With Previously Treated Squamous Cell Non-small Cell Lung Cancer

Squamous-cell Non-Small-cell Lung Cancer

China
Sinocelltech Ltd.

Withdrawn

A Study to Evaluate Efficacy and Safety of the Combination of SCTA01 & SCTA01C in Outpatients With COVID-19

COVID-19
Sinocelltech Ltd.

Completed

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Coronavirus Disease 2019(COVID-19)

China
Sinocelltech Ltd.

Completed

Pharmacokinetics and Safety in Healthy Volunteers

Healthy

China
Sinocelltech Ltd.

Active, not recruiting

The Purpose of This Research Study is to Compare the Efficacy and Safety of SCT630 and Adalimumab (HUMIRA®) in Adults With Plaque Psoriasis

Psoriasis

China
Sinocelltech Ltd.

Unknown

The Study of Drug SCT510A in Patients With Wet Age-related Macular Degeneration (wAMD)

Wet Age-related Macular Degeneration
Sinocelltech Ltd.

Unknown

Study of SCT-I10A Combined SCT200 or SCT-I10A Combined SCT200 Plus Chemotherapy in ESCC and CRC

Colorectal Cancer | Esophageal Squamous Cell Carcinoma
Sinocelltech Ltd.

Unknown

Safety and Efficacy of SCT200 in Patients With Relapsed or Metastatic Triple Receptor Negative Breast Cancer

Triple Negative Breast Neoplasms

China
Sinocelltech Ltd.

Unknown

Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of SCT200 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Sinocelltech Ltd.

Unknown

Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A

Hemophilia A

China

3

Subscribe